ArticlePloS one2023

Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.

Barry D Hock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.